D

Taysha Gene Therapies, Inc. TSHA

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.97$4.18
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Net Income -39.13M -46.64M -42.41M -27.85M -32.73M
Total Depreciation and Amortization 257.00K 291.00K 295.00K 299.00K 286.00K
Total Amortization of Deferred Charges -- -- -- 0.00 147.00K
Total Other Non-Cash Items 6.00M 1.15M 5.89M 7.90M 4.10M
Change in Net Operating Assets -47.00K 4.77M -4.65M -7.07M 4.03M
Cash from Operations -32.91M -40.43M -40.88M -26.72M -24.17M
Capital Expenditure -443.00K 1.00K -24.00K -250.00K -108.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 0.00 0.00 -3.00M 3.00K 60.00K
Cash from Investing -443.00K 1.00K -3.02M -247.00K -48.00K
Total Debt Issued -- -- -- 0.00 49.85M
Total Debt Repaid -- -- -- 0.00 -40.61M
Issuance of Common Stock 1.05M 216.58M 692.00K 49.61M --
Repurchase of Common Stock -- -- -- -- -173.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -260.00K 75.00K 19.00K -57.00K -271.00K
Cash from Financing 785.00K 216.66M 711.00K 49.56M 8.80M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -32.57M 176.23M -43.19M 22.59M -15.42M